Karen L Kamholz

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. doi request reprint Implementing change: steps to initiate a human donor milk program in a US Level III NICU
    Karen L Kamholz
    Department of Pediatrics, Boston University School of Medicine, Boston, MA 02118, USA
    J Hum Lact 28:128-31. 2012
  2. doi request reprint Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trial
    Karen L Kamholz
    Division of Neonatology, Boston Medical Center, 771 Albany Street, Boston, MA 02118, USA
    Arch Dis Child Fetal Neonatal Ed 97:F93-8. 2012
  3. doi request reprint Cost-effectiveness of early treatment for retinopathy of prematurity
    Karen L Kamholz
    Department of Pediatrics, Boston Medical Center, Boston, MA 02118, USA
    Pediatrics 123:262-9. 2009
  4. doi request reprint Economic evaluation of caffeine for apnea of prematurity
    Dmitry Dukhovny
    Division of Newborn Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Pediatrics 127:e146-55. 2011

Collaborators

  • John A F Zupancic
  • Haresh Kirpalani
  • Robin K Whyte
  • Barbara Schmidt
  • W Tin
  • L W Doyle
  • A Ohlsson
  • E Hey
  • A Bairam
  • Cynthia H Cole
  • Dmitry Dukhovny
  • K Saunders
  • R Lontis
  • M Bhiladvala
  • Na Wang
  • G Ford
  • J Tomlinson
  • W Amos
  • B Lemyre
  • N Embleton
  • P Pudenz
  • G Turner
  • V Launoy
  • C Barnett
  • K Philipp
  • E McGean
  • M Gent
  • P Huppi
  • E Kelly
  • L Spellen
  • J D'llario
  • H Maclean
  • D Moddemann
  • T Mulder
  • A Ghys
  • K Sankaran
  • J Keng
  • P Grier
  • K Nesbitt
  • E Asztalos
  • W Fraser
  • R Haslam
  • A Chalaf
  • S Gray
  • M Khairy
  • S Belanger
  • M Perlman
  • S Fritz
  • J Vachon
  • Scott A Lorch
  • H Fahnenstich
  • L Kuhn
  • Joke H Kok
  • M Lacorte
  • C Chambers
  • K Callanan
  • P Proctor
  • D Royer
  • H Lagercrantz
  • M Rogers
  • H Halliday
  • N Granke
  • A Solimano
  • R Alvaro
  • H Walti
  • S Ferland
  • J Kok
  • M Lacy
  • L Scapinello
  • D Nuytemans
  • L Goodchild
  • K Barrington
  • K Penner
  • D Hohn
  • I Netter
  • C Tan-Dy
  • D McMillan
  • C Cummings
  • G Opie
  • B Faber
  • M Offringa
  • E Shinwell
  • J Cairnie
  • C Porter
  • C Poets
  • A van Wassenaer
  • K Thorpe
  • D Davis
  • E Goldstein
  • S Meskell

Detail Information

Publications4

  1. doi request reprint Implementing change: steps to initiate a human donor milk program in a US Level III NICU
    Karen L Kamholz
    Department of Pediatrics, Boston University School of Medicine, Boston, MA 02118, USA
    J Hum Lact 28:128-31. 2012
    ..This paper describes the steps taken and the obstacles overcome to initiate a PDM program for our hospital's tiniest, sickest, and most vulnerable patients...
  2. doi request reprint Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trial
    Karen L Kamholz
    Division of Neonatology, Boston Medical Center, 771 Albany Street, Boston, MA 02118, USA
    Arch Dis Child Fetal Neonatal Ed 97:F93-8. 2012
    ..However, a post-hoc analysis expanding the definition of NDI to include borderline intellectual functioning (Mental Development Index (MDI) <85) found an improvement in outcomes in the group maintained at higher haemoglobin levels...
  3. doi request reprint Cost-effectiveness of early treatment for retinopathy of prematurity
    Karen L Kamholz
    Department of Pediatrics, Boston Medical Center, Boston, MA 02118, USA
    Pediatrics 123:262-9. 2009
    ..However, early treatment increased the frequency of laser therapy, anesthesia with intubation, treatment-related systemic complications, and the need for repeat treatments...
  4. doi request reprint Economic evaluation of caffeine for apnea of prematurity
    Dmitry Dukhovny
    Division of Newborn Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Pediatrics 127:e146-55. 2011
    ..To determine the cost-effectiveness of treatment with caffeine compared with placebo for apnea of prematurity in infants with birth weights less than 1250 g, from birth through 18 to 21 months' corrected age...